LaBaer Heads to Arizona State for New Biomarker Initiative | GenomeWeb

In an effort to add to Arizona's personalized medicine initiative, the Biodesign Institute at Arizona State University and the Virginia G. Piper Charitable Trust have hired Harvard's Joshua LaBaer to head the new Virginia G. Piper Center for Personalized Diagnostics. LaBaer will collaborate with teams from the larger Partnership for Personalized Medicine, which includes TGen in Phoenix and the Fred Hutchinson Cancer Research Center in Seattle.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.